Neurobiology of Schizophrenia

[1]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[2]  R. Shprintzen,et al.  Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Pearlson,et al.  Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach , 1996, Trends in Neurosciences.

[4]  E. G. Jones,et al.  Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. , 1996, Archives of general psychiatry.

[5]  S. Arnold,et al.  Further Evidence of Abnormal Cytoarchitecture of the Entorhinal Cortex in Schizophrenia Using Spatial Point Pattern Analyses , 1997, Biological Psychiatry.

[6]  J. Gilmore,et al.  Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia , 1997, Schizophrenia Research.

[7]  M. Hatten,et al.  New directions for neuronal migration , 1998, Current Opinion in Neurobiology.

[8]  B. Turetsky,et al.  P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention , 1998, Schizophrenia Research.

[9]  J. Trojanowski,et al.  Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. , 1998, Archives of general psychiatry.

[10]  High Rates of Schizophrenia in Adults With Velo-Cardio-Facial Syndrome , 1999 .

[11]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[12]  P. Goldman-Rakic,et al.  The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.

[13]  P. Goldman-Rakic,et al.  The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia , 1999, Biological Psychiatry.

[14]  R. Yolken,et al.  Endogenous retroviruses and schizophrenia , 2000, Brain Research Reviews.

[15]  David A Lewis,et al.  Catching Up on Schizophrenia Natural History and Neurobiology , 2000, Neuron.

[16]  D. Blake,et al.  Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain* , 2001, The Journal of Biological Chemistry.

[17]  R. Buchanan,et al.  A separate disease within the syndrome of schizophrenia. , 2001, Archives of general psychiatry.

[18]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J S Sinsheimer,et al.  Chromosome 1 loci in Finnish schizophrenia families. , 2001, Human molecular genetics.

[20]  D J Porteous,et al.  Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. , 2001, American journal of human genetics.

[21]  S. Snyder,et al.  Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Peter B. Jones,et al.  Obstetric complications and schizophrenia: historical and meta-analytic review. , 2002, The American journal of psychiatry.

[23]  C. Walsh,et al.  Smooth, rough and upside-down neocortical development. , 2002, Current opinion in genetics & development.

[24]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[25]  P. Patterson,et al.  Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness , 2002, Current Opinion in Neurobiology.

[26]  P. Falkai.  The Neuropathology of Schizophrenia , 2002 .

[27]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[28]  E. Susser,et al.  In utero infection and adult schizophrenia. , 2002, Mental retardation and developmental disabilities research reviews.

[29]  D. Javitt,et al.  Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. , 2002, The American journal of psychiatry.

[30]  M Tohyama,et al.  Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth , 2003, Molecular Psychiatry.

[31]  Douglas L Falls,et al.  Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.

[32]  Naoki Oiso,et al.  Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1) , 2003, Nature Genetics.

[33]  Marek Kubicki,et al.  Recent structural and functional imaging findings in schizophrenia , 2003 .

[34]  Christopher P Austin,et al.  DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. , 2003, Human molecular genetics.

[35]  Bita Moghaddam,et al.  Bringing Order to the Glutamate Chaos in Schizophrenia , 2003, Neuron.

[36]  W. Dobyns,et al.  Lissencephaly and the molecular basis of neuronal migration. , 2003, Human molecular genetics.

[37]  C. Austin,et al.  DISC1 (Disrupted in Schizophrenia‐1) is expressed in limbic regions of the primate brain , 2003, Neuroreport.

[38]  Sheila Christie,et al.  Yeast two-hybrid screens implicate DISC1 in brain development and function. , 2003, Biochemical and biophysical research communications.

[39]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[40]  J. Suvisaari,et al.  Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies , 2003, Schizophrenia Research.

[41]  Michael F. Green,et al.  Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study , 2003, Psychopharmacology.

[42]  Takahisa Taguchi,et al.  Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. , 2004, Human molecular genetics.

[43]  H. Verdoux.  Perinatal risk factors for schizophrenia: How specific are they? , 2004, Current psychiatry reports.

[44]  J. Gold.  Cognitive deficits as treatment targets in schizophrenia , 2004, Schizophrenia Research.

[45]  A. Singleton,et al.  The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. , 2004, Human molecular genetics.

[46]  M. Tohyama,et al.  DISC1 localizes to the centrosome by binding to kendrin. , 2004, Biochemical and biophysical research communications.

[47]  Michael F. Green,et al.  Identification of separable cognitive factors in schizophrenia , 2004, Schizophrenia Research.

[48]  Elena Antonova,et al.  The relationship between brain structure and neurocognition in schizophrenia: a selective review , 2004, Schizophrenia Research.

[49]  J. Rain,et al.  Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders , 2004, Molecular and Cellular Neuroscience.

[50]  N. Brandon,et al.  Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment , 2004, Molecular Psychiatry.

[51]  Raquel E Gur,et al.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. , 2004, The Journal of clinical investigation.

[52]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[53]  J L Rapoport,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[54]  Dennis Velakoulis,et al.  Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. , 2005, Schizophrenia bulletin.

[55]  A. Meyer-Lindenberg,et al.  Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  T. Akiyama,et al.  A functional link between Disrupted-In-Schizophrenia 1 and the eukaryotic translation initiation factor 3. , 2005, Biochemical and biophysical research communications.

[57]  P. Sham,et al.  Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. , 2005, JAMA.

[58]  Stephan Eliez,et al.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome , 2005, Nature Neuroscience.

[59]  Tyrone D. Cannon,et al.  Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. , 2005, Archives of general psychiatry.

[60]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[61]  D J Porteous,et al.  Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[62]  E. J. van den Oord,et al.  Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. , 2005, The American journal of psychiatry.

[63]  C. Ross,et al.  What is the role of protein aggregation in neurodegeneration? , 2005, Nature Reviews Molecular Cell Biology.

[64]  K. Davis,et al.  Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. , 2005, International review of neurobiology.

[65]  Jennifer E. Chubb,et al.  DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling , 2005, Science.

[66]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[67]  A. Addington,et al.  Dysbindin (DTNBP1, 6p22.3) is Associated with Childhood-Onset Psychosis and Endophenotypes Measured by the Premorbid Adjustment Scale (PAS) , 2005, Journal of autism and developmental disorders.

[68]  Li-Huei Tsai,et al.  Nucleokinesis in Neuronal Migration , 2005, Neuron.

[69]  D. Brat,et al.  The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[70]  L. DeLisi,et al.  A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder , 2005, Molecular Psychiatry.

[71]  Carl-Fredrik Westin,et al.  The Application of DTI to Investigate White Matter Abnormalities in Schizophrenia , 2005, Annals of the New York Academy of Sciences.

[72]  N. Craddock,et al.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis , 2005, Journal of Medical Genetics.

[73]  Christopher A. Ross,et al.  A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development , 2005, Nature Cell Biology.

[74]  Andrew B West,et al.  Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[75]  N. Wray,et al.  Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population , 2005, Molecular Psychiatry.

[76]  M J Owen,et al.  Schizophrenia: genes at last? , 2005, Trends in genetics : TIG.

[77]  Jie Qin,et al.  Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice , 2005, Nature Neuroscience.

[78]  Michael C O'Donovan,et al.  Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. , 2005, Human molecular genetics.

[79]  Chih-Chiang Chiu,et al.  Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. , 2005, Archives of general psychiatry.

[80]  T. Crow,et al.  Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. , 2005, The American journal of psychiatry.

[81]  Chang-Gyu Hahn,et al.  Neurodevelopment, neuroplasticity, and new genes for schizophrenia. , 2005, Progress in brain research.

[82]  Philip D. Harvey,et al.  Cognition in schizophrenia: impairments, determinants, and functional importance. , 2005, The Psychiatric clinics of North America.

[83]  S. Faraone,et al.  Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[84]  C. Ross,et al.  Neurogenetics: insights into degenerative diseases and approaches to schizophrenia , 2005, Clinical Neuroscience Research.

[85]  Tyrone D. Cannon,et al.  The inheritance of intermediate phenotypes for schizophrenia , 2005, Current opinion in psychiatry.

[86]  G. Kirov,et al.  Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. , 2005, Archives of general psychiatry.

[87]  Avshalom Caspi,et al.  Gene–environment interactions in psychiatry: joining forces with neuroscience , 2006, Nature Reviews Neuroscience.

[88]  S. Snyder,et al.  Dopamine Receptor Excess and Mouse Madness , 2006, Neuron.

[89]  M. Hampson,et al.  Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder , 2006, Molecular Psychiatry.

[90]  Birgit Funke,et al.  Genetic variation in DTNBP1 influences general cognitive ability. , 2006, Human molecular genetics.

[91]  L. Peltonen,et al.  Genes and schizophrenia: beyond schizophrenia: the role of DISC1 in major mental illness. , 2005, Schizophrenia bulletin.

[92]  Paul J. Harrison,et al.  atechol-o-Methyltransferase , Cognition , nd Psychosis : Val 158 Met and Beyond , 2006 .

[93]  Paul J. Harrison,et al.  Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology , 2006, Biological Psychiatry.

[94]  D. Weinberger,et al.  Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models , 2006, Biological Psychiatry.

[95]  F. McMahon,et al.  G72/G30 in Schizophrenia and Bipolar Disorder: Review and Meta-analysis , 2006, Biological Psychiatry.

[96]  C. Pichard,et al.  The Dutch Famine of 1944–1945: a pathophysiological model of long-term consequences of wasting disease , 2006, Current opinion in clinical nutrition and metabolic care.

[97]  L Elliot Hong,et al.  Familial aggregation of eye-tracking endophenotypes in families of schizophrenic patients. , 2006, Archives of general psychiatry.

[98]  David J. Porteous,et al.  The Genetics and Biology of Disc1—An Emerging Role in Psychosis and Cognition , 2006, Biological Psychiatry.

[99]  Daniel R Weinberger,et al.  Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. , 2006, Human molecular genetics.

[100]  G. Kirov,et al.  Evidence that a DISC1 frame-shift deletion associated with psychosis in a single family may not be a pathogenic mutation , 2006, Molecular Psychiatry.

[101]  Sabine Landau,et al.  Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study. , 2006, The American journal of psychiatry.

[102]  A. Sawa,et al.  A Review of Disrupted-in-Schizophrenia-1 (disc1): Neurodevelopment, Cognition, and Mental Conditions , 2006, Biological Psychiatry.

[103]  Stephen Lawrie,et al.  Brain–behaviour relationships in people at high genetic risk of schizophrenia , 2006, NeuroImage.

[104]  J. Lieberman,et al.  Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. , 2006, The American journal of psychiatry.

[105]  Karin E. Borgmann-Winter,et al.  Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia , 2006, Nature Medicine.

[106]  M C O'Donovan,et al.  The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons , 2006, Molecular Psychiatry.

[107]  P. DeRosse,et al.  Dysbindin genotype and negative symptoms in schizophrenia. , 2006, The American journal of psychiatry.

[108]  D. Porteous,et al.  Disrupted in schizophrenia 1: building brains and memories. , 2006, Trends in molecular medicine.

[109]  Brien Riley,et al.  Molecular genetic studies of schizophrenia , 2006, European Journal of Human Genetics.

[110]  Hiroko Koike,et al.  Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[111]  Daniel R. Weinberger,et al.  Schizophrenia Genes - Famine to Feast , 2006, Biological Psychiatry.

[112]  G. D’Arcangelo.  Reelin mouse mutants as models of cortical development disorders , 2006, Epilepsy & Behavior.

[113]  Paul J. Harrison,et al.  Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond , 2006, Biological Psychiatry.

[114]  J. Coyle,et al.  Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis , 2006, Cellular and Molecular Neurobiology.

[115]  E. Kandel,et al.  Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning , 2006, Neuron.

[116]  C. Freitag,et al.  DTNBP1 (Dysbindin) Gene Variants Modulate Prefrontal Brain Function in Healthy Individuals , 2006, Neuropsychopharmacology.

[117]  Cameron S Carter,et al.  Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. , 2005, Schizophrenia bulletin.

[118]  E. Bramon,et al.  Is there an association between the COMT gene and P300 endophenotypes? , 2006, European Psychiatry.

[119]  R. Kucherlapati,et al.  Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome , 2006, Neurogenetics.

[120]  Jessica A. Turner,et al.  Imaging phenotypes and genotypes in schizophrenia , 2007, Neuroinformatics.

[121]  R. Margolis,et al.  Huntington’s Disease-Like 2 , 2008 .

[122]  Gareth J. Barker,et al.  Diffusion tensor imaging in schizophrenia , 2008, European Psychiatry.